A trial average is not a promise. The Wegovy pill works for most people who take it as prescribed, but the pattern of results — and the pace — varies. This is a realistic, honest timeline of what to expect, based on how oral semaglutide actually behaves in the OASIS-4 trial and in clinic.
Weeks 1–4: the starter dose (1.5mg)
The first month is about tolerating the medicine and getting the routine right. The dose is deliberately low to let your gut adjust. The most reliable early sign that it's working is not the scale — it's your appetite. Portions feel like too much sooner. The background "food noise" that pulls you toward snacks quietens down. The number on the scale may barely move yet, and that's normal.
Focus this month on:
- Taking the tablet correctly — empty stomach, a sip of water, 30-minute wait.
- Building a morning routine that protects that 30-minute window.
- Managing any early nausea with smaller, blander meals.
Months 2–3: titrating (4mg then 9mg)
As you step up to 4mg and then 9mg, the appetite effect becomes more obvious. For most people steady, gentle weight loss begins here — usually a modest amount per week rather than dramatic drops. Each dose step can bring a short return of nausea for a few days that usually settles.
Months 4–6: maintenance (25mg)
By around four months, people who tolerate the titration reach the 25mg maintenance dose. Weight loss usually continues at a steady pace for those who adhere to the tablet's timing rules and keep a reasonable diet and activity pattern alongside. Some people settle on 9mg if that's giving them the response they need — the "right" dose is the lowest one that delivers results you're happy with.
By around 64 weeks
In OASIS-4, average body-weight loss on oral semaglutide 25mg was about 14%, rising to around 16.6% for people who took it as prescribed throughout the trial. Roughly one in three participants lost 20% or more of their body weight. Those are averages — some people lose more, some less, and the number reached depends heavily on the dose you get to, how strictly you follow the 30-minute rule, and the food and activity patterns around the medicine.
Plateaus are normal
Weight loss rarely moves in a straight line. Most people hit at least one plateau — a few weeks where the scale barely shifts. This is not the medicine failing. The body defends weight; a plateau often ends by itself, sometimes with small changes to protein intake, sleep, or resistance activity. If it lasts and you're at maintenance dose, that's a pharmacist conversation, not a reason to double up.
If it isn't working
A minority of people respond less well. If you've been on the maintenance dose for around three months and there's genuinely been very little response — with the tablet taken correctly — it's reasonable to review. Sometimes the answer is switching format (to the injection) or medicine. That's a clinical decision, not a personal failure.
Frequently asked questions
How soon will I lose weight? Often modest movement in months 2–3 as you titrate. Meaningful loss usually accrues over months, not weeks.
How much will I lose? The trial average at 25mg is about 14% over 64 weeks (around 16.6% when taken as prescribed). Individual results vary.
Why has my weight loss plateaued? Plateaus are normal. Small changes to diet, activity or sleep often restart progress. Don't take extra tablets to try to break one.
What if it's not working? If there's very little response after around three months at maintenance dose, ask your pharmacist for a review — including whether a different format or medicine would suit you better.
References
- Wharton S, et al. Oral semaglutide 25 mg in adults with overweight or obesity (OASIS-4). N Engl J Med 2025.
- Knop FK, et al. Oral semaglutide 50 mg for weight loss (OASIS-1). Lancet 2023.
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP-1). N Engl J Med 2021.
Reviewed by Jimah Alsaai MPharm, GPhC 2232652, Superintendent Pharmacist, Solira.